跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Omnipaque 240 5.18g/10mL Injection Vial
Approved
STANDARD
Omnipaque 240 5.18g/10mL Injection Vial
GE Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
939541ef25ce76e8
Company
GE Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
939541ef25ce76e8
Product Name
Omnipaque 240 5.18g/10mL Injection Vial
Artg Id
12596
Artg Name
OMNIPAQUE 240 iohexol 5.18g/10mL injection vial
Sponsor
GE Healthcare Australia Pty Ltd
Company Detail Path
/organization/ge-healthcare-australia-pty-limited
Artg Date
1991-09-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ae1456a2cd85c06a5e50bdef66a530b8.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/142fe65bb4b2a2427d51e1a781b48278.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
939541ef25ce76e8
Type
Standard
Back to TGA Approvals
Omnipaque 240 5.18g/10mL Injection Vial - TGA Drug Approval Details